Does lopinavir/ritonavir alter the primary gingival epithelium?


In clinical practice, a significant proportion of HIV-infected patients receive lopinavir/ritonavir (LPV/r) as a component of highly active antiretroviral therapy (HAART). The study by Israr et al. was designed to evaluate the effects of the HIV protease inhibitor LPV/r on gingival epithelium growth and differentiation. The authors isolated gingival… (More)
DOI: 10.1586/eri.10.138


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.